Posted On: 10/14/2014 3:03:13 PM
Post# of 30036
Lol....if I was to "adopt a middle-aged man" my wife would certainly do a double take!
Amarantus is a bargain now, and actually shows resilience in today's trading session. As I said earlier, it only takes 1 or 2 impatient longs to sell their holdings to drop the sp significantly as we see today. But, who knows.
I really don't think the general market movements affect AMBS (DJIA, NYSE etc.), after all, it's a pre-revenue bio play on the OTC. That being said, it's a pre-revenue bio play with admirable science attached and don't think that a major pharma company doesn't take notes on the AMBS pipeline they have accumulated to date. MANF is the big carrot though and it's early in it's development. I would just love to pick GC's brain though or be the fly on the wall...
Sit back and enjoy the ride...hopefully the "self-proclaimed experts" don't sway those that have been accumulating to date and have been holding as long as many have, as frustrating as it has been at times...
Amarantus is a bargain now, and actually shows resilience in today's trading session. As I said earlier, it only takes 1 or 2 impatient longs to sell their holdings to drop the sp significantly as we see today. But, who knows.
I really don't think the general market movements affect AMBS (DJIA, NYSE etc.), after all, it's a pre-revenue bio play on the OTC. That being said, it's a pre-revenue bio play with admirable science attached and don't think that a major pharma company doesn't take notes on the AMBS pipeline they have accumulated to date. MANF is the big carrot though and it's early in it's development. I would just love to pick GC's brain though or be the fly on the wall...
Sit back and enjoy the ride...hopefully the "self-proclaimed experts" don't sway those that have been accumulating to date and have been holding as long as many have, as frustrating as it has been at times...
(0)
(0)Scroll down for more posts ▼
